東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Quantum chemistry methods for oncolo...

Albuquerque, Eudenilson L.,

Linked to FindBook

Google Book

Amazon

博客來

Quantum chemistry methods for oncological drugs /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Quantum chemistry methods for oncological drugs // Eudenilson L. Albuquerque.
Author:	Albuquerque, Eudenilson L.,
Published:	Amsterdam, Netherlands :Elsevier, : c2024.,
Description:	xiv, 288 p. :ill. ;24 cm.
[NT 15003449]:	Front Cover -- Quantum Chemistry Methods for Oncological Drugs -- Copyright Page -- Dedication -- Contents -- Preface -- I. Quantum chemistry: A review -- 1 From classical to quantum physics -- 1.1 Classical physics -- 1.1.1 Ancient Greece -- 1.1.2 Aristotelian science -- 1.1.3 Galileo's ideas -- 1.1.4 Newtonian mechanics -- 1.2 Failures of classical physics -- 1.2.1 Blackbody radiation -- 1.2.2 The photoelectric effect -- 1.2.3 The Compton effect -- 1.3 The old quantum theory -- 1.3.1 Wilson-Sommerfeld quantization rule -- 1.3.2 1D simple harmonic oscillator -- 1.3.3 The hydrogen atom
[NT 15003449]:	1.4 Conclusions -- References -- 2 Main theoretical results -- 2.1 Introduction -- 2.2 Lagrangian mechanics -- 2.3 Hamiltonian mechanics -- 2.4 Schrödinger equation -- 2.5 The postulates of quantum mechanics -- 2.6 The electronic spin angular momentum -- 2.7 Perturbation theory -- 2.8 Conclusions -- References -- 3 Computational approach -- 3.1 Introduction -- 3.2 Chemical bonds -- 3.2.1 Ionic bonds -- 3.2.2 Covalent bonds -- 3.2.3 Hydrogen bonds -- 3.2.4 van der Waals interaction -- 3.3 Born-Oppenheimer approximation -- 3.4 Many-particle systems -- 3.4.1 Hartree method.
[NT 15003449]:	3.4.2 Hartree-Fock method -- 3.5 Density functional theory -- 3.6 Kohn-Sham approach -- 3.7 Exchange-correlation functionals -- 3.8 Molecular fractional with conjugate caps method -- 3.9 Conclusions -- References -- II. Immune-oncological drugs -- 4 Cancer immunotherapy -- 4.1 Introduction -- 4.2 The human immune system -- 4.3 The immune checkpoint proteins -- 4.4 Main immune-oncological drugs -- 4.5 Conclusions -- References -- 5 Immune-oncological drug atezolizumab -- 5.1 Introduction -- 5.2 Materials and methods -- 5.2.1 Drug-receptor complex data -- 5.2.2 Quantum interaction energies.
[NT 15003449]:	5.3 Main results and discussions -- 5.3.1 PD-L1/Atezolizumab recognition surface -- 5.3.2 Electrostatic potential isosurfaces -- 5.4 Conclusions -- References -- 6 Immune-oncological drug nivolumab -- 6.1 Introduction -- 6.2 Materials and methods -- 6.2.1 Drug-receptor complex data -- 6.2.2 Quantum interaction energies -- 6.3 Main results and discussions -- 6.3.1 PD-1/Nivolumab recognition surface -- 6.3.2 PD-1/PD-L1 recognition surface -- 6.4 Conclusions -- References -- 7 Immune-oncological drug pembrolizumab -- 7.1 Introduction -- 7.2 Materials and methods -- 7.2.1 Drug-receptor complex data.
[NT 15003449]:	7.2.2 Quantum interaction energies -- 7.3 Main results and discussions -- 7.3.1 PD-1/Pembrolizumab-HC recognition surface -- 7.3.2 PD-1/Pembrolizumab-LC recognition surface -- 7.4 Conclusions -- References -- 8 Immune-oncological drug ipilimumab -- 8.1 Introduction -- 8.2 Materials and methods -- 8.2.1 Drug-receptor complex data -- 8.2.2 Quantum interaction energies -- 8.3 Main results and discussions -- 8.3.1 CTLA-4/ipilimumab-heavy chain recognition surface -- 8.3.2 CTLA-4/ipilimumab-light chain recognition surface -- 8.4 Conclusions -- References -- 9 Optoelectronics properties.
Subject:	Antineoplastic agents. -
ISBN:	9780443155307

Quantum chemistry methods for oncological drugs /
Albuquerque, Eudenilson L.,

Quantum chemistry methods for oncological drugs /Eudenilson L. Albuquerque. - Amsterdam, Netherlands :Elsevier,c2024. - xiv, 288 p. :ill. ;24 cm.

Includes bibliographical references and index.

Front Cover -- Quantum Chemistry Methods for Oncological Drugs -- Copyright Page -- Dedication -- Contents -- Preface -- I. Quantum chemistry: A review -- 1 From classical to quantum physics -- 1.1 Classical physics -- 1.1.1 Ancient Greece -- 1.1.2 Aristotelian science -- 1.1.3 Galileo's ideas -- 1.1.4 Newtonian mechanics -- 1.2 Failures of classical physics -- 1.2.1 Blackbody radiation -- 1.2.2 The photoelectric effect -- 1.2.3 The Compton effect -- 1.3 The old quantum theory -- 1.3.1 Wilson-Sommerfeld quantization rule -- 1.3.2 1D simple harmonic oscillator -- 1.3.3 The hydrogen atom

ISBN: 9780443155307US200Subjects--Topical Terms:

3812609
Antineoplastic agents.

LC Class. No.: RC271.C5

Dewey Class. No.: 616.994061

Quantum chemistry methods for oncological drugs /
LDR:03714cam a2200253 a 4500 001 2423733
005 20240419111852.0
008 260520s2024 ne a b 001 0 eng d
020 $a 9780443155307 $q (pbk.) : $c US200
020 $a 0443155305 $q (pbk.)
020 $z 9780443155314 $q (ebk.)
020 $z 0443155313 $q (ebk.)
035 $a (OCoLC)1424922786
040 $a YDX $b eng $c YDX $d OCLCO $d EBLCP $d OPELS $d OCLCO $d UKAHL
050 # 4 $a RC271.C5
082 0 4 $a 616.994061
100 1 $a Albuquerque, Eudenilson L., $e author. $3 3812608
245 1 0 $a Quantum chemistry methods for oncological drugs / $c Eudenilson L. Albuquerque.
260 # $a Amsterdam, Netherlands : $b Elsevier, $c c2024.
300 $a xiv, 288 p. : $b ill. ; $c 24 cm.
504 $a Includes bibliographical references and index.
505 0 # $a Front Cover -- Quantum Chemistry Methods for Oncological Drugs -- Copyright Page -- Dedication -- Contents -- Preface -- I. Quantum chemistry: A review -- 1 From classical to quantum physics -- 1.1 Classical physics -- 1.1.1 Ancient Greece -- 1.1.2 Aristotelian science -- 1.1.3 Galileo's ideas -- 1.1.4 Newtonian mechanics -- 1.2 Failures of classical physics -- 1.2.1 Blackbody radiation -- 1.2.2 The photoelectric effect -- 1.2.3 The Compton effect -- 1.3 The old quantum theory -- 1.3.1 Wilson-Sommerfeld quantization rule -- 1.3.2 1D simple harmonic oscillator -- 1.3.3 The hydrogen atom
505 8 # $a 1.4 Conclusions -- References -- 2 Main theoretical results -- 2.1 Introduction -- 2.2 Lagrangian mechanics -- 2.3 Hamiltonian mechanics -- 2.4 Schrödinger equation -- 2.5 The postulates of quantum mechanics -- 2.6 The electronic spin angular momentum -- 2.7 Perturbation theory -- 2.8 Conclusions -- References -- 3 Computational approach -- 3.1 Introduction -- 3.2 Chemical bonds -- 3.2.1 Ionic bonds -- 3.2.2 Covalent bonds -- 3.2.3 Hydrogen bonds -- 3.2.4 van der Waals interaction -- 3.3 Born-Oppenheimer approximation -- 3.4 Many-particle systems -- 3.4.1 Hartree method.
505 8 # $a 3.4.2 Hartree-Fock method -- 3.5 Density functional theory -- 3.6 Kohn-Sham approach -- 3.7 Exchange-correlation functionals -- 3.8 Molecular fractional with conjugate caps method -- 3.9 Conclusions -- References -- II. Immune-oncological drugs -- 4 Cancer immunotherapy -- 4.1 Introduction -- 4.2 The human immune system -- 4.3 The immune checkpoint proteins -- 4.4 Main immune-oncological drugs -- 4.5 Conclusions -- References -- 5 Immune-oncological drug atezolizumab -- 5.1 Introduction -- 5.2 Materials and methods -- 5.2.1 Drug-receptor complex data -- 5.2.2 Quantum interaction energies.
505 8 # $a 5.3 Main results and discussions -- 5.3.1 PD-L1/Atezolizumab recognition surface -- 5.3.2 Electrostatic potential isosurfaces -- 5.4 Conclusions -- References -- 6 Immune-oncological drug nivolumab -- 6.1 Introduction -- 6.2 Materials and methods -- 6.2.1 Drug-receptor complex data -- 6.2.2 Quantum interaction energies -- 6.3 Main results and discussions -- 6.3.1 PD-1/Nivolumab recognition surface -- 6.3.2 PD-1/PD-L1 recognition surface -- 6.4 Conclusions -- References -- 7 Immune-oncological drug pembrolizumab -- 7.1 Introduction -- 7.2 Materials and methods -- 7.2.1 Drug-receptor complex data.
505 8 # $a 7.2.2 Quantum interaction energies -- 7.3 Main results and discussions -- 7.3.1 PD-1/Pembrolizumab-HC recognition surface -- 7.3.2 PD-1/Pembrolizumab-LC recognition surface -- 7.4 Conclusions -- References -- 8 Immune-oncological drug ipilimumab -- 8.1 Introduction -- 8.2 Materials and methods -- 8.2.1 Drug-receptor complex data -- 8.2.2 Quantum interaction energies -- 8.3 Main results and discussions -- 8.3.1 CTLA-4/ipilimumab-heavy chain recognition surface -- 8.3.2 CTLA-4/ipilimumab-light chain recognition surface -- 8.4 Conclusions -- References -- 9 Optoelectronics properties.
650 # 0 $a Antineoplastic agents. $3 3812609
650 # 0 $a Quantum chemistry. $3 519235